Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 4/20 | 0.53 |
| ▸ | CDC25B | P30305 | 4/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | IDO1 | P14902 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | BLM | P54132 | 2/20 | 0.53 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.53 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | GSR | P00390 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL28060681 | 0.90 | SOAT1 (0.50) | CDC25ACDC25BMAPTMAPK1MEN1 | |
| SCHEMBL30172862 | 0.82 | BACE1 (0.52) | CDC25ACDC25BMAPTMAPK1MEN1 | |
| SCHEMBL1243588 | 0.82 | BACE1 (0.52) | CDC25ACDC25BMAPTMAPK1MEN1 | |
| SCHEMBL31315022 | 0.81 | CDC25B (0.55) | CDC25ACDC25BMAPTMAPK1MEN1 | |
| SCHEMBL15514574 | 0.81 | CDC25B (0.55) | CDC25ACDC25BMAPTMAPK1MEN1 | |
| SCHEMBL30645249 | 0.80 | CDC25B (0.47) | CDC25ACDC25BMAPTMEN1KMT2A | |
| SCHEMBL28865505 | 0.80 | CDC25A (0.48) | CDC25ACDC25BMAPTMAPK1MEN1 | |
| SCHEMBL11264139 | 0.80 | CDC25B (0.48) | CDC25ACDC25BMAPTMAPK1MEN1 | |
| SCHEMBL4116666 | 0.79 | SOAT1 (0.50) | CDC25ACDC25BMAPTMAPK1MEN1 | |
| SCHEMBL5968250 | 0.78 | CDC25A (0.47) | CDC25ACDC25BMAPTMAPK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 539 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3861039-B1 | HYDROGEL COMPOSITIONS | OPHTALMIC CIE (FR) | 2023-11-01 | — | — | EP | claimed |
| US-20210332174-A1 | HYDROGEL COMPOSITIONS | OPHTALMIC COMPAGNIE (FR) | 2021-10-28 | — | — | US | claimed |
| CN-113166340-A | Hydrogel composition | 眼科公司 | 2021-07-23 | — | — | CN | claimed |
| US-20110123721-A1 | ENZYMATIC SYNTHESIS OF POLYOL ACRYLATES | BASF AKTIENGESELLSCHAFT (DE) | 2011-05-26 | — | — | US | claimed |
| US-4460674-A | GALLIC ACID DERIVATIVES AND NAPOHTHOQUINONES | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1984-07-17 | — | — | US | claimed |
| CN-122056781-A | Two-part dental sealant, method of administration with a syringe device, and kit | 舒万诺知识产权公司 | 2026-05-19 | — | — | CN | disclosed |
| US-12559631-B2 | Thermally curable two-component coating compounds | BASF SE (DE) | 2026-02-24 | — | — | US | disclosed |
| US-20250368830-A1 | METHOD FOR TRANSFERRING AN EMBOSSED STRUCTURE TO THE SURFACE OF A COATING, AND COMPOSITE EMPLOYABLE AS EMBOSSING MOLD | BASF COATINGS GMBH (DE) | 2025-12-04 | — | — | US | disclosed |
| US-12386253-B2 | Method for transferring an embossed structure to the surface of a coating, and composite employable as embossing mold | BASF COATINGS GMBH (DE) | 2025-08-12 | — | — | US | disclosed |
| US-20250215122-A1 | CURABLE COMPOSITION FOR 3D PRINTING PROCESS AND 3D-PRINTED OBJECT FORMED THEREFROM AND 3D PRINTING PROCESS USING THE SAME | BASF SE (DE) | 2025-07-03 | — | — | US | disclosed |
| US-20250178271-A1 | METHOD FOR TRANSFERRING AN EMBOSSED STRUCTURE TO THE SURFACE OF A COATING AND COMPOUND STRUCTURE CONTAINING SAID COATING | BASF COATINGS GMBH (DE) | 2025-06-05 | — | — | US | disclosed |
| US-20250129263-A1 | CURABLE COMPOSITION AND 3D-PRINTED OBJECT FORMED THEREFROM AND PROCESS FOR FORMING THE SAME | BASF SE (DE) | 2025-04-24 | — | — | US | disclosed |
| CN-1095078-A | The photopolymer composition that is used for the aniline forme that to process at water-bearing media | GRACE W R & CO (US) | 1994-11-16 | — | — | CN | disclosed |
| US-5364741-A | Printing plates | W. R. GRACE & CO.-CONN. (US) | 1994-11-15 | — | — | US | disclosed |
| US-5328805-A | Printing plates with acrylated polymers and chain extenders | W. R. GRACE & CO.-CONN. (US) | 1994-07-12 | — | — | US | disclosed |
| CN-1083493-A | Water-developable photosensitive polyurethane- (meth) acrylate | GRACE W R & CO (US) | 1994-03-09 | — | — | CN | disclosed |
| US-4752547-A | RECORDING LAYER CONTAINS REDUCING AGENT, LEWIS BASE COMPLEX, AND REDUCIBLE DYE FORMING COMPOUND | EASTMAN KODAK COMPANY (US) | 1988-06-21 | — | — | US | disclosed |
| US-4727008-A | MULTILAYER-IMAGEWISE EXPOSURE TO ELECTRICAL CHARGES OF DIFFERENT POLARITIES TO GIVE DEVELOPABLE IMAGES | EASTMAN KODAK COMPANY (US) | 1988-02-23 | — | — | US | disclosed |
| US-4460674-A | GALLIC ACID DERIVATIVES AND NAPOHTHOQUINONES | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1984-07-17 | — | — | US | disclosed |
| US-4237057-A | KALAFUNGIN AND 9-DEOXYKALAFUNGIN | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1980-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559631-B2 | Thermally curable two-component coating compounds | ESD, MGMT, MTHFD2 | CDC25A 2352/4885CDC25B 1585/4885MAPT 1446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.